Mechanisms underlying myosin heavy chain expression during development of the rat diaphragm muscle IN THE RAT DIAPHRAGM MUSCLE (Dia m ), significant changes in myosin heavy chain (MHC) isoform expression occur during the first 4 wk of postnatal development (22-24, 38, 39, 41) . Most fibers express protein for the MHC Neo isoform at birth (P-0), but the relative expression of this isoform gradually decreases until it disappears by postnatal day 28 (P-28). In contrast, MHC 2X and MHC 2B protein isoforms are not expressed in the rat Dia m until at least the second postnatal week. Postnatal development of the rat Dia m is also characterized by changes in muscle contractile properties and by significant growth of muscle fibers, most notably those expressing MHC 2X and MHC 2B (15, 22, 36, 38, 42, 43, 45, 47) . Thus the relative MHC isoform composition changes during postnatal development of the Dia m , and ultimately it determines Dia m function. At the present time, very little is known about the underlying mechanisms regulating MHC phenotype expression.
Previous studies of postnatal development, both in limb muscles and the Dia m , have focused exclusively on changes in the relative protein expression of the different MHC isoforms in the whole muscle (9, 11, 22-24, 30, 31, 33, 38, 39, 45) . However, during postnatal development of the rat Dia m , MHC content (measured by MHC mass per half-sarcomere volume and fiber cross-sectional area) increases markedly (15) . This increase varies across fiber types (classified based on MHC isoform expression). At single Dia m fibers, the developmental increase in MHC content is greater in fibers expressing MHC 2X and/or MHC 2B isoforms than in those expressing MHC Slow or MHC 2A . Thus, during postnatal development, not only do Dia m fibers increase in size but also they increase their MHC protein content. This substantial increase in total MHC protein expression across Dia m fiber types is not evident if only the relative expression of MHC isoform is examined.
The period from birth to adulthood provides a unique and significant opportunity to examine the mechanisms underlying rapid muscle growth and phenotype transitions. In rat limb muscles, postnatal muscle phenotype is regulated by MHC gene expression either as a result from mechanical stretch induced by skeletal growth and/or increased muscle activity (18) . At present, there is no direct information regarding the transcriptional regulation of MHC isoform expression during postnatal development of the rat Dia m .
An increase in MHC protein of the rat Dia m during postnatal development could be due to transcriptional, translational, and/or posttranslational mechanisms, which may vary depending on fiber type (10) . Assuming transcriptional rate remains constant, an increase in mRNA expression would result in increased protein expression. For example, patterns of MHC isoform-specific mRNA and protein expression are very similar during postnatal development in pigs (25) . We hypothesized that postnatal transitions in MHC isoform mRNA expression in the rat Dia m are followed by concordant changes in MHC protein expression. To address this question, measurements of MHC mRNA and protein were performed using quantitative real-time RT-PCR and SDS-PAGE, respectively, at postnatal days 0, 14 (P-14), and 28 and in the adult [postnatal day 84 (P-84)] rat Dia m .
days of gestation, and pups were randomly assigned to one of the three developmental time points at birth. Up until postnatal day 21, pups were housed with their lactating mothers at which time they were weaned and placed in separate cages under a 12:12-h light-dark cycle. Adult rats and postweaning pups were fed with Purina rat chow and provided with water ad libitum. Body weights were monitored daily in all groups. Different animals were used for mRNA and protein measurements at each developmental time point. The Institutional Animal Care and Use Committee of the Mayo Clinic approved all procedures.
MHC Isoform mRNA Expression
RNA extraction. The whole Dia m was excised in all groups except in the adult where only the right costal Diam was obtained (n ϭ 6 for each age group). The Diam samples were rapidly frozen in liquid nitrogen and stored at Ϫ80°C until analyzed. Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA) following the manufacturer's protocol. RNA concentration was determined spectrophotometrically at a wavelength of 260 nm. To assess RNA integrity, the ratio of 260-and 280-nm measurements was obtained and verified to be in the range of 1.8 -2.1. Before real-time RT-PCR, microfluidic technology using the BioAnalyzer 2100 (Agilent Technologies, Palo Alto, CA) was used to confirm quantitation and integrity results, in accordance with the manufacturer's protocol.
Quantitation of MHC mRNA. To quantify mRNA amounts across Dia m samples and MHC isoforms, a real-time RT-PCR technique was developed using a synthetic mimic as an internal control where the mimic spans a fragment of the gene target and contains the same primer pair for real-time PCR.
CONSTRUCTION OF REAL-TIME RT-PCR INTERNAL CONTROL. PCR primers were designed for real-time RT-PCR using LightCycler Probe Design software (version 1.0, Roche Molecular). It was not possible, however, to design reliable primer pairs for the MHC 2B isoform suitable for real-time RT-PCR using a mimic internal control. This isoform is usually expressed at low levels and rarely is singly expressed (15, 37) , and thus it is unlikely to produce a measurable impact on conclusions regarding MHC transitions during postnatal development. To document any relative change in MHC 2B mRNA expression across developmental time points, Northern blot analyses of MHC 2B mRNA were conducted, as previously described (13) .
Mimic internal control DNA was created for each MHC isoform by oligonucleotide overlap extension and amplification by PCR with the respective mimic or MHC composite primer pairs ( Table 1 ). The PCR product was then agar purified to eliminate any nonspecific PCR product. The purified mimic product was incubated with 5 units of Taq polymerase and 1 pmol of dATP at 72°C for 15 min to create a 3Ј(A) overhang, cloned into the pCR-4 TOPO vector using the TOPO TA Cloning Kit for Sequencing (Invitrogen), and transformed into bacteria. Correct insertion of the mimic DNA was confirmed by sequencing performed at the Molecular Biology Core Facility, Mayo Clinic. Mimic internal control cRNA was generated by in vitro transcription using the MAXIscript T3/T7 transcription kit (Ambion) with linearized vector DNA as template. Either T7 RNA polymerase (for the MHC 2A isoform) or T3 RNA polymerase (for the other MHC isoforms) was used to drive in vitro transcription as appropriate. Isoform-specific mimic cRNA was then treated with 10 units of RNase-free DNase I (Roche), purified through a NucAway spin column (Ambion), and quantitated spectrophotometrically. Tenfold serial dilutions of mimic cRNA were then used in real-time RT-PCR.
REVERSE TRANSCRIPTION. Total Diam RNA (1.0 g) and titrated amounts of mimic cRNA were reverse transcribed using the SuperScript first-strand synthesis system for RT-PCR (Invitrogen) following the kit protocol. Briefly, sample RNA, 0.5 l of oligo(dT) (0.5 g/l), 0.5 l of random primers (50 ng/l), 1 l of 10 mM dNTP, and RNase-free sterile water to 10 l were incubated at 65°C for 5 min and chilled on ice for 1 min to denature RNA. A mix with 2 l of 10ϫ RT buffer, 4 l of 25 mM MgCl2, 1 l of RNaseOUT RNase inhibitor, and 2 l of 0.1 M dithiothreitol was then added to each sample and incubated at room temperature for 2 min. After this, 50 units of SuperScript II RT were added to each sample. Samples were then incubated 10 min at room temperature, 50 min at 42°C, 15 min at 70°C, and placed on ice. All reverse transcription reactions were done in triplicate.
REAL-TIME PCR. For gene expression analysis, 2 l of the reverse transcription reaction was added to a reaction mix containing 1ϫ SYBRgreen I Master (Roche Molecular), 2.0 mM MgCl2, and 0.5 M of the respective primer pair (5Ј and 3Ј primers in Table 1 ). Amplification and quantitation of MHC isoform mRNA were performed on a LightCycler (Roche Molecular) with the following parameters: 10 min at 95°C followed by 33-37 cycles of 15 s at 95°C, 10 s at 58°C, and 24 s at 72°C. Fluorescence measurements were taken at the end of each cycle (product extension period). After amplification, a melting curve analysis was performed to verify amplification product specificity. Briefly, amplification products were denatured at 95°C, and then they were quickly cooled to 65°C for 15 s. Products were then heated at a rate of 0.1°C/s to a final temperature of 95°C while continuously measuring fluorescence. The derivative of the melting curve fluorescence was plotted vs. temperature, thus yielding melting peaks indicative of products generated during amplification (Fig. 1A) . The lack of primer-dimer complexes and the presence of an appropriate single peak in the resultant melting curve were indicators of correct amplification products. These products were subsequently sequenced to confirm the nature of the amplified product. All PCR reactions were performed in duplicate for each reverse transcription product.
QUANTITATIVE ANALYSES. An amplification fluorescence plot was generated for each sample with LightCycler software (version 3.5.3, Roche Molecular) using the second-derivative method (Fig. 1B) . From this plot, a threshold cycle value was calculated that corresponds to the cycle number at which fluorescence was detected above threshold. This threshold cycle value was used to calculate the initial amount of target cDNA. A linear relationship was obtained by plotting the threshold cycle and the logarithm of the mimic cDNA dilution used as an internal control for each MHC isoform. Comparison to the respective standard permitted determination of the MHC isoform mRNA concentration for each Diam sample. *These primers were used for construction of the synthetic mimic internal control by oligonucleotide overlap extension and amplification by PCR. MHC, myosin heavy chain; Tm, melting temperature. 
MHC Isoform Protein Expression
Protein extraction. In additional animals (n ϭ 6 for each age group), the Diam was rapidly excised as described above. The Diam samples were rapidly frozen in isopentane cooled in liquid nitrogen and stored at Ϫ80°C until analyzed. Myosin protein was extracted as previously reported (13, 15) . Briefly, muscle segments were minced in a high-salt solution (300 mM NaCl, 100 mM NaH 2PO4, 50 mM Na2HPO4, 1 mM Na4P2O7, 10 mM EDTA, pH 6.5), and extracts were incubated at 4°C for 30 min (7). Extracts were then centrifuged and supernatants recovered. A 10-l aliquot of supernatant was diluted (1:10) in a low-salt buffer consisting of 1 mM EDTA and 0.1% 2-mercaptoethanol (vol/vol) and stored overnight at 4°C to allow precipitation of myosin filaments. The filament solution was subsequently centrifuged to form a pellet, which was then dissolved in myosin sample buffer (500 mM CaCl 2, 10 mM NaH2PO4), followed by a 1:200 dilution in SDS sample buffer [62.5 mM Tris, 2% SDS (wt/vol), 10% glycerol, 5% 2-mercaptoethanol (vol/vol), and 0.001% bromophenol blue (wt/vol at pH 6.8)]. The samples were boiled for 2 min and stored at Ϫ80°C.
Gel electrophoresis. Different MHC protein isoforms were electrophoretically separated by SDS-PAGE. A modification of the procedure by Sugiura and Murakami (40) was used to prepare the gel. A 3.5% acrylamide concentration (pH 6.8) was used in the stacking gel, and the resolving gel (8 ϫ 10 cm in size, 0.75 mm thick) consisted of a gradient of 5-8% acrylamide (pH 8.8) with 25% glycerol (vol/vol). Increasing volumes of a known concentration of purified rabbit myosin (Sigma, St. Louis, MO) were loaded on the gels [standard myosin concentrations verified with the Bradford method (5)]. All samples were run at a constant current of 20 mA/gel until the tracking dye reached the bottom of the gel (ϳ1.75 h). After completion of the gel run, the gels were removed from the plates and silver-stained according to the procedure of Oakley et al. (29) . All MHC isoforms were identified based on their migration pattern, and their relative expression was quantified by densitometry measurements on a highresolution (300 dpi) digital scan (Microtek ScanMaker 5) of each gel. The brightness-area product of each rabbit myosin sample was determined from the area and average brightness of each densitometric band after subtraction of local background. A linear relationship between the brightness-area product and the myosin content across rabbit myosin samples was used to determine the myosin content in the individual rat Dia m samples. This method has been previously described and validated (13, 14, 16) . For each Diam sample, MHC content was normalized to the tissue weight.
Identification of MHC isoforms by migration patterns was verified by Western blot analysis as previously described (16, 17) . Briefly, rat Dia m bundles were run on SDS-PAGE and transferred to nitrocellulose overnight. The nitrocellulose sheet was divided into six sections, and one segment was stained with colloidal gold to ensure adequate protein transfer and visualize protein migration. One of the following mouse monoclonal or polyclonal antibodies was used to stain the five additional segments: anti-MHC Neo (IgG, Novocastra, Newcastle, UK); NCL (IgG, Novocastra), which reacts with MHCSlow; SC.71 (IgG, ATCC, Manassas, VA), which reacts with MHC2A; BF-F3 (IgM, Schiaffino), which reacts with MHC2B; and BF-35 (IgG, Schiaffino), which reacts with all isoforms but MHC2X. Isoform specificity of these antibodies has been previously determined (20, 34) . The nitrocellulose segments were stained with a biotinylated secondary antibody specific to IgG or IgM as appropriate, and they were visualized with alkaline phosphatase (Vectastain ABC kit, Vector Laboratories, Burlingame, CA).
Statistical Analysis
All statistical analyses were performed using standard statistical software (JMP 6.0.0, SAS Institute, Cary, NC). MHC protein concentration and MHC mRNA concentration were compared across different MHC isoforms and across developmental and adult samples by two-way ANOVA with MHC isoform and age as grouping variables (F ratio values are reported for each comparison). When appropriate, least squares mean differences across MHC isoforms and age were compared post hoc using a Student's t-test (with Bonferroni correction), and specific t values are reported. Statistical significance was considered at a P value Ͻ0.05.
RESULTS

MHC mRNA Expression During Postnatal Development
On average, 0.57 Ϯ 0.07 g of total RNA/mg tissue was extracted from Dia m across all developmental time points (Fig.  2) . There was a nonstatistically significant trend toward a decrease in the amount of total RNA extracted from Dia m samples with increasing postnatal age (F ϭ 1.91; P ϭ 0.16).
Quantitation of MHC mRNA isoform expression. The amount of MHC Neo , MHC Slow , MHC 2A , and MHC 2X mRNA was measured using real-time RT-PCR at P-0, P-14, and P-28 and in the adult. There were significant changes in the expression of isoform-specific MHC mRNA during the postnatal development of the Dia m (F ϭ 19.3; P Ͻ 0.0001). Figure 3 shows the amount of isoform-specific MHC mRNA throughout development, and Table 2 presents the relative amounts of each MHC isoform at each postnatal time point. Expression of MHC 2B mRNA was determined from Northern blots (data not shown). Importantly, there was no significant change in the relative expression of this isoform throughout postnatal development. At P-0, the predominant mRNA isoform expressed was MHC Slow , accounting for ϳ40% of all MHC mRNA. Between P-0 and P-14, mRNA expression for the MHC Neo isoform increased significantly and at P-14, MHC Neo accounted for ϳ80% of all MHC mRNA. There was no significant change in the amount of MHC Slow , MHC 2A or MHC 2X isoform mRNA expressed. However, the expression of MHC Slow and MHC 2A mRNA decreased relative to all MHC mRNA, with each of these adult isoforms, accounting for Ͻ10% of all MHC mRNA.
From P-14 to P-28, the amount of MHC Neo mRNA decreased significantly returning to near P-0 levels accounting for ϳ30% of all MHC mRNA. The amount of MHC Slow and MHC 2X mRNA increased slightly, with each accounting for ϳ30% of all MHC mRNA expressed. The amount of MHC 2A mRNA did not change during this period, even when expressed relative to all MHC mRNA expressed.
Between P-28 and adulthood, MHC Neo mRNA continued to decrease accounting for ϳ1% of all MHC mRNA expressed. The amount of mRNA for MHC Slow and MHC 2X isoforms increased further (P Ͻ 0.05), with each isoform accounting for ϳ45% of all MHC mRNA in the adult Dia m . The amount of MHC 2A mRNA was again unchanged, accounting for 7% of all MHC mRNA.
MHC Protein Expression During Postnatal Development
Total MHC protein normalized by tissue weight changed during development (Fig. 2) . The amount of total MHC protein peaked at P-14 (F ϭ 5.38; P ϭ 0.005). Total MHC protein levels in the adult (ϳ3.7 g MHC/g tissue) were consistent with previous results (13) and were similar to P-0 levels.
MHC protein expression. Based on measurements of total MHC protein and the relative expression of each isoform, the amount of protein represented by each isoform was calculated at each time point. A significant change in MHC isoform expression was evident during postnatal development of the Dia m (F ϭ 7.60; P Ͻ 0.0001). Figure 4 shows the amount of isoform-specific MHC protein throughout development, and 
Correlation Between MHC mRNA and Protein Expression During Postnatal Development
To assess any proportionate changes in MHC mRNA and protein levels, we calculated the ratio of MHC protein to mRNA at each developmental time point after normalizing for tissue weight (Fig. 5) . At any one time point, there were considerable differences in the ratio of protein to mRNA across isoforms. In general, the protein expression was relatively greater for the MHC Neo and MHC 2A isoforms (ϳ50 g of protein/pg of mRNA) compared with the MHC Slow and MHC 2X isoforms (ϳ10 g of protein/pg of mRNA).
Comparing the temporal expression profile of MHC isoform mRNA and protein in the developing rat Dia m , it was evident that isoform-specific mRNA and protein levels did not necessarily show corresponding changes. To compare across isoforms, only relative changes in the protein-to-mRNA ratio were considered (normalized to the peak ratio for each isoform). In this analysis, when the change in MHC isoform protein expression parallels the change in mRNA, a line of slope zero is obtained. A greater increase in protein expression relative to the change in mRNA yields a line with a positive slope; conversely, a smaller change in protein expression relative to the change in mRNA yields a line with a negative slope.
Between P-0 and P-14, the MHC protein-to-mRNA ratio decreased for the MHC Neo and MHC 2A isoforms, reflecting a greater increase in mRNA than in protein expression. In contrast, protein expression of the MHC Slow and MHC 2X isoforms increased to a greater extent than mRNA. Beyond P-14, the lack of protein for the MHC Neo isoform causes the slope of the protein-to-mRNA ratio to approach zero. Between P-14 and P-28, the MHC protein-to-mRNA ratio for the MHC Slow and MHC 2A isoforms has a positive slope, reflecting the greater increase in protein relative to mRNA levels. Beyond P-14, the slope of the protein to mRNA ratio for the MHC 2X isoform was negative, reflecting the increasing mRNA levels despite unchanged protein levels. Between P-28 and adulthood, the slope of the protein-to-mRNA ratio for the MHC Slow and MHC 2A isoforms was negative, reflecting an increase in mRNA with stable or decreasing protein levels. These comparisons highlight isoform-specific differences in the temporal pattern of MHC mRNA and protein expression.
DISCUSSION
The results of the present study demonstrate that during a period of rapid muscle growth and increase in MHC protein, changes in MHC mRNA expression are not concordant, particularly for the adult MHC isoforms. Indeed, the amount of MHC protein does not correspond to the mRNA levels across isoforms or over time. Thus MHC protein expression appears not to be solely under transcriptional control during postnatal development of the rat Dia m . These are novel findings, sug- 
Values are means Ϯ SE. (F ϭ 34.9; P Ͻ 0.0001; post hoc t ϭ 1.99). *Significant difference from P-14 values, P Ͻ 0.05. †Significant difference from P-28 values, P Ͻ 0.05. ‡Significant difference from adult values, P Ͻ 0.05. gesting important developmental differences in MHC isoform mRNA and protein expression.
Contradictory findings exist regarding the correlation between MHC isoform mRNA and protein expression in skeletal muscle. In pigs, the expression patterns of isoform-specific MHC mRNA and protein were very similar during postnatal development in the longissimus and rhomboideus muscles (predominantly composed of fibers expressing MHC 2X and/or MHC 2B vs. MHC Slow isoforms, respectively) (25) . During early stages of development, parallel changes in MHC isoform mRNA and protein expression were also reported in the rabbit Dia m (28) and several other skeletal muscles (26) . These findings contrast with the present report during development of the rat Dia m . Only the postnatal changes in MHC Neo protein expression were matched by changes in mRNA expression. Other studies have shown that the correlation between MHC mRNA and protein expression becomes weaker during development (2, 46) and in conditions associated with rapid transformations in fiber composition (3, 13, 35) .
Concordant changes in mRNA and protein expression would suggest a role for transcription in the control of MHC protein expression. Thus it is possible that MHC Neo is under transcriptional control in the postnatal rat Dia m . However, this is does not appear to be the case for other (adult) MHC isoforms in the rat. Although the amount of MHC protein increased throughout early development and peaked by P-28 for the MHC Slow and MHC 2X isoforms, mRNA expression remained relatively constant up to P-28 and then increased into adulthood. There was little relation between the changes in mRNA and protein expression for the MHC 2A isoform. Expression of the MHC 2B mRNA isoform was evident early in development despite lack of protein expression, and mRNA expression remained relatively constant throughout postnatal development. The apparent inconsistency in MHC isoform-specific mRNA and protein expression may relate to species-, muscle-, or isoform-specific differences. Nevertheless, knowledge of isoform-specific MHC mRNA levels does not allow for prediction of the levels of protein expression during a period of rapid fiber growth of the rat Dia m , emphasizing the need for comprehensive studies that examine MHC isoform-specific mRNA and protein levels.
The marked transitions in MHC isoform mRNA and/or protein expression observed during postnatal development of the rat Dia m are in general agreement with the reports of several previous studies. However, most previous studies were not comprehensive, precluding analyses of the postnatal control of MHC isoform expression. Kelly and colleagues (23) reported MHC mRNA and protein for MHC Neo , MHC 2A , and MHC 2B ; their results are limited by the fact that MHC Slow and MHC 2X isoforms comprise over 50% of the total MHC protein in the adult Dia m . The absence of information relating to postnatal changes in expression of these abundantly expressed MHC isoforms is a major deficiency. Changes in MHC isoform expression have been reported by electrophoretic separation of MHC proteins in the whole Dia m and single fibers (22, 24, 38, 39) or analysis of Dia m cross sections (24, 41) . In a previous study on single rat Dia m fibers (15), significant fiber growth was evident postnatally. The increase in MHC protein was greatest in fibers expressing MHC 2X and/or MHC 2B isoforms, in agreement with the results of the present study where MHC 2X and MHC 2B protein expression increased to a greater extent than MHC 2A and MHC Slow in the whole rat Dia m .
The increase in relative composition and total MHC protein content of the MHC 2X and MHC 2B isoforms likely contributes to the differing contractile properties of the postnatal rat Dia m (15, 22, 36, 38, 42, 44, 45, 47) . The neonatal Dia m relies on shallow, rapid breaths, partly because of the highly compliant neonatal chest wall but also due to the inability of the neonatal Dia m to generate sufficient force to accommodate deeper breaths. Throughout postnatal development, the chest wall becomes less compliant, and recruitment of fatigable, fasttwitch motor units innervating MHC 2X and MHC 2B isoforms is possible. These transitions in MHC isoform expression are consistent with the effect of stretch and muscle activity on fiber phenotype of rat limb muscles (18) . The increase in relative protein expression of MHC 2X and MHC 2B isoforms, as well as increased MHC protein content in these fibers, allows for a wider range of functional requirements and motor behaviors in the adult rat Dia m compared with the neonate.
The underlying mechanisms for postnatal transitions in MHC isoform expression are currently unknown. Several possibilities include the pattern of innervation or removal of nerve-derived trophic influences, changing hormonal levels (e.g., for thyroid or growth hormones), the degree of weightbearing activity, and/or genetically determined developmental program(s). Whether innervation of skeletal muscles plays a critical role in the isoform transitions observed during postnatal development is controversial. From embryological day 18 (19) up until P-14, rat Dia m innervation is polyneuronal (4, 12) , and, therefore, MHC isoform expression in the rat Dia m can be influenced by more than one motoneuron during the first 2 postnatal wk. Coincident with the completion of synapse elimination and the withdrawal of polyneuronal innervation, expression of MHC 2X and MHC 2B protein isoforms occurs, and their relative expression continues to increase through P-28 when the adult pattern of MHC isoform expression is fully established. This suggests a potential role for innervation in regulation of MHC isoform protein expression. However, previous studies have suggested that innervation is not a requirement for the ultimate expression of adult fast MHC protein isoforms (6, 8, 27, 32) . Furthermore, during postnatal development of the rat Dia m , removal of innervation with unilateral denervation only delayed expression of fast MHC protein isoforms and prolonged expression of the MHC Neo protein isoform (39) . Therefore, changes in the pattern of innervation or removal of neural influence may modulate the timing of MHC isoform transitions during postnatal development, but these factors alone do not seem to control postnatal MHC isoform expression in skeletal muscle.
Regulatory processes other than transcriptional control likely contribute significantly to the overall transitions in composition of the rat Dia m during early postnatal development, especially for the adult MHC isoforms. Although it appears that a number of factors can modulate postnatal MHC expression, MHC isoform transitions may ultimately depend on preprogrammed fiber type differences. Although changes in the innervation pattern, removal of innervation, and low thyroid levels may alter the timing of postnatal MHC isoform transitions (1, 21, 38) , the MHC phenotypes present in the adult are ultimately expressed. Taken together, the results from this and previous studies indicate there are complex differential regulatory mechanisms that control MHC isoform expression in the rat Dia m during postnatal development. Future studies will need to focus on the signaling pathways and underlying transcriptional and/or translational mechanisms governing MHC isoform-specific plasticity in skeletal muscle.
